Sign in
4

Changes in Ownership

ArriVent BioPharma, Inc. Filed Acc 0001104659-26-010477

Options or other derivatives

  • President of R&D acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lutzker Stuart President of R&D 2026-02-02 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X05/tm265104-3_4seq1.xml…